The Different Types of Dermatologic Toxicities With ADCs

A couple of patients that we presented at SGO who were on the Innovate 3 trial and one of them had fairly significant dermatologic toxicity. It was a unique like when we first evaluated eye toxicity with ADCs. We are going to continue to learn about how to best take care of the skin hopefully if the trial is positive I hope it is because it gives our patients another option.